RMD

BUY

ResMed Inc.

Health Care

0.95

PEGY ratio

Rank #166

Why This Matters

This stock appears undervalued relative to its growth and dividend yield. Strong projected growth of 17.6% annually over 5 years. Pays a 1.3% dividend yield.

RMD trades at 18.0x earnings against 17.6% growth + 1.3% yield (PEGY 0.95). Valuation looks favorable — the price is not fully reflecting the growth and yield on offer.

~ Growth estimate uses historical CAGR (forward estimates unavailable)

• Growth rate derived from historical CAGR — limited analyst coverage.

Scan date: 2026-06-02

Valuation

18.0x

P/E Ratio

Growth

17.6%

5yr EPS

Income

1.3%

Div Yield

PEGY Components

PEGY Score0.95

Denominator18.9%

EPS (TTM)$10.37

Market Data

Price$186.44

ExchangeNYSE

S&P 500

What Changed

PEGY Score

1.06→0.95(-0.11)

Zone

Hold→Buy

Rank

#195→#166(+29 positions)

vs 7 days ago

Portfolio Context

Founder does not hold this stock.

Not in your portfolio.

Sector: Health Care

PEGY History — 90 days

I Want to Invest Not Right Now

Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only